HUTCHMED Highlights Clinical Data to be Presented at ESMO&#x

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 16, 2023 -- HUTCHMED Limited today announces that new and updated clinical data from several ongoing studies of fruquintinib, in...

Related Keywords

Wuhan , Hubei , China , Nanjing , Jiangsu , Spain , Lu Wang , Liaoning , Shanghai , Hong Kong , Madrid , Japan , Wenhua Li , Pei Ma , Eli Lilly , Xiaoli Wei , Ben Atwell Alex Shaw , Fuxiang Zhou , Zhou Yi , Devices Agency , European Society For Medical Oncology , European Medicines Agency , First Affiliated Hospital Of Nanjing Medical University , China National Medical Products Administration , Linkedin , China Limited , Department Of Radiation , Department Of Oncology , Nasdaq , Zhongnan Hospital Of Wuhan University , Drug Administration , Department Of Gastrointestinal Medical Oncology , Exchange Commission , Harbin Medical University Cancer Hospital , Fudan University Shanghai Cancer Center , Japan Pharmaceuticals , Stock Exchange Of Hong Kong , European Society , Medical Oncology , Gastrointestinal Medical Oncology , Zhongnan Hospital , Wuhan University , First Affiliated Hospital , Nanjing Medical University , Priority Review , Prescription Drug User Fee Act , Medical Devices Agency , Securities Litigation Reform Act , New Drug Application , Stock Exchange , Hong Kong Limited , Alex Shaw , Freddy Crossley , Daphne Zhang , Markets ,